TY - JOUR
T1 - The Medical Treatment of Inflammatory Breast Cancer
AU - Dawood, Shaheenah
AU - Ueno, Naoto T.
AU - Cristofanilli, Massimo
PY - 2008/2
Y1 - 2008/2
N2 - The multidisciplinary management of inflammatory breast cancer (IBC) includes neoadjuvant systemic chemotherapy, surgery, radiotherapy, and, in hormone receptor-positive disease, hormonal therapy. The use of induction chemotherapy with anthracyclines and taxanes somewhat improved the prognosis and local control of patients with IBC compared to local modalities alone. Improved understanding of the biological features of the disease has allowed for the development of targeted therapies (eg, trastuzumab and lapatinib) that are changing the outcome of this aggressive disease.
AB - The multidisciplinary management of inflammatory breast cancer (IBC) includes neoadjuvant systemic chemotherapy, surgery, radiotherapy, and, in hormone receptor-positive disease, hormonal therapy. The use of induction chemotherapy with anthracyclines and taxanes somewhat improved the prognosis and local control of patients with IBC compared to local modalities alone. Improved understanding of the biological features of the disease has allowed for the development of targeted therapies (eg, trastuzumab and lapatinib) that are changing the outcome of this aggressive disease.
UR - http://www.scopus.com/inward/record.url?scp=39549115429&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=39549115429&partnerID=8YFLogxK
U2 - 10.1053/j.seminoncol.2007.11.012
DO - 10.1053/j.seminoncol.2007.11.012
M3 - Article
C2 - 18308147
AN - SCOPUS:39549115429
SN - 0093-7754
VL - 35
SP - 64
EP - 71
JO - Seminars in Oncology
JF - Seminars in Oncology
IS - 1
ER -
